Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $769 at Truist Securities

April 29, 2026 4:21 PM
Truist Securities analyst Greg Renza lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $769.00 (from $801.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change